121 related articles for article (PubMed ID: 15074556)
1. Differential diagnosis of solid carcinoma in situ.
Maluf HM
Semin Diagn Pathol; 2004 Feb; 21(1):25-31. PubMed ID: 15074556
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
4. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
Choi YJ; Pinto MM; Hao L; Riba AK
Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
[TBL] [Abstract][Full Text] [Related]
5. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.
Bratthauer GL; Moinfar F; Stamatakos MD; Mezzetti TP; Shekitka KM; Man YG; Tavassoli FA
Hum Pathol; 2002 Jun; 33(6):620-7. PubMed ID: 12152161
[TBL] [Abstract][Full Text] [Related]
6. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
7. American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.
Schnitt SJ; Brogi E; Chen YY; King TA; Lakhani SR
Ann Diagn Pathol; 2020 Apr; 45():151481. PubMed ID: 32120324
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
9. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases.
Rakha EA; Abbas A; Sheeran R
Pathobiology; 2016; 83(5):221-7. PubMed ID: 27116593
[TBL] [Abstract][Full Text] [Related]
10. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
Dabbs DJ; Bhargava R; Chivukula M
Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
[TBL] [Abstract][Full Text] [Related]
11. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
Han A; Xiong M; Li Z; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
[TBL] [Abstract][Full Text] [Related]
12. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
Ross DS; Hoda SA
Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
15. The role of immunohistochemistry in the differential diagnosis of breast lesions.
Moriya T; Kozuka Y; Kanomata N; Tse GM; Tan PH
Pathology; 2009 Jan; 41(1):68-76. PubMed ID: 19089742
[TBL] [Abstract][Full Text] [Related]
16. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
Lee AH
J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
[TBL] [Abstract][Full Text] [Related]
17. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
[No Abstract] [Full Text] [Related]
18. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.
Baqai T; Shousha S
Histopathology; 2003 May; 42(5):440-7. PubMed ID: 12713620
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]